Bonus & Incentive Agreements in the Biotechnology Industry

4,936 Contracts & Agreements

Browse by Company

4D Molecular Therapeutics Inc (8 contracts)
89bio, Inc. (1)
AbbVie Inc. (16)
ABEONA THERAPEUTICS INC. (3)
ACADIA PHARMACEUTICALS INC (13)
ACCELERON PHARMA INC (21)
Accustem Sciences Inc. (1)
Achaogen, Inc. (14)
ACHIEVE LIFE SCIENCES, INC. (8)
Acorda Therapeutics (6)
Actinium Pharmaceuticals, Inc. (3)
Acumen Pharmaceuticals, Inc. (2)
Acurx Pharmaceuticals, LLC (1)
Adagio Therapeutics, Inc. (5)
Adamas Pharmaceuticals Inc (8)
Adhera Therapeutics, Inc. (9)
ADiTx Therapeutics, Inc. (2)
ADMA BIOLOGICS, INC. (1)
ADURO BIOTECH, INC. (12)
Advaxis, Inc. (1)
Adverum Biotechnologies, Inc. (13)
Aeglea BioTherapeutics, Inc. (13)
Aerovate Therapeutics, Inc. (4)
AGENUS INC (19)
AgeX Therapeutics, Inc. (1)
AGIOS PHARMACEUTICALS INC (14)
AILERON THERAPEUTICS INC (13)
Aimmune Therapeutics, Inc. (4)
AKCEA THERAPEUTICS, INC. (6)
Akebia Therapeutics, Inc. (23)
Akero Therapeutics, Inc. (1)
ALBIREO PHARMA, INC. (15)
Aldeyra Therapeutics, Inc. (9)
Alector, Inc. (5)
Alexion Pharmaceuticals (25)
Aligos Therapeutics, Inc. (9)
Alkermes plc. (47)
Allakos Inc. (3)
Allarity Therapeutics, Inc. (1)
Allena Pharmaceuticals, Inc. (3)
Alliqua BioMedical, Inc. (12)
Allogene Therapeutics, Inc. (2)
Allovir, Inc. (2)
ALNYLAM PHARMACEUTICALS, INC. (43)
Alpha Healthcare Acquisition Corp. (10)
ALPINE IMMUNE SCIENCES, INC. (8)
Altimmune, Inc. (11)
ALX ONCOLOGY HOLDINGS INC (2)
AMARILLO BIOSCIENCES INC (3)
AMARIN CORP PLC (16)
AMERICAN CRYOSTEM Corp (2)
Amgen Inc. (81)
AMICUS THERAPEUTICS, INC. (22)
AmpliPhi Biosciences Corp (3)
Amplitude Healthcare Acquisition Corp (5)
ANAPTYSBIO INC (3)
Anika Therapeutics (18)
Anixa Biosciences Inc (4)
Annexon, Inc. (9)
Annovis Bio, Inc. (3)
Apellis Pharmaceuticals, Inc. (9)
APPLIED GENETIC TECHNOLOGIES CORP (9)
Applied Molecular Transport Inc. (7)
Applied Therapeutics Inc. (8)
Aprea Therapeutics, Inc. (2)
Aptevo Therapeutics Inc. (4)
AquaBounty Technologies, Inc. (4)
AQUINOX PHARMACEUTICALS, INC (6)
Aravive, Inc. (4)
Arbutus Biopharma Corp (6)
ARCA biopharma, Inc. (29)
Arcellx, Inc. (3)
Arcturus Therapeutics Holdings Inc. (2)
Arcus Biosciences, Inc. (4)
Arcutis Biotherapeutics, Inc. (4)
ARDELYX, INC. (10)
ARENA PHARMACEUTICALS INC (50)
ARROWHEAD PHARMACEUTICALS, INC. (6)
Arsanis, Inc. (26)
Artiva Biotherapeutics, Inc. (10)
ARYA Sciences Acquisition Corp II (4)
ASSEMBLY BIOSCIENCES, INC. (18)
Atara Biotherapeutics, Inc. (10)
Athenex, Inc. (4)
ATHERSYS, INC (25)
ATOSSA GENETICS INC (11)
Atreca, Inc. (3)
aTYR PHARMA INC (8)
Aura Biosciences, Inc. (3)
Aurinia Pharmaceuticals Inc. (1)
AVEO PHARMACEUTICALS INC (10)
Avid Bioservices, Inc. (17)
Avidity Biosciences, Inc. (5)
Avita Therapeutics, Inc. (1)
AVROBIO, Inc. (8)
Axcella Health Inc. (4)
Axovant Sciences Ltd. (7)
Ayala Pharmaceuticals, Inc. (1)
AZIYO BIOLOGICS, INC. (4)
AzurRx BioPharma, Inc. (2)
BCTG Acquisition Corp. (3)
Beam Therapeutics Inc. (8)
BeiGene, Ltd. (49)
BELLICUM PHARMACEUTICALS, INC (20)
Benitec Biopharma Inc. (3)
BICYCLE THERAPEUTICS Ltd (3)
Big Cypress Acquisition Corp. (1)
BIO-PATH HOLDINGS INC (19)
bioAffinity Technologies, Inc. (4)
BioAtla, Inc. (2)
BioCardia, Inc. (7)
BIOCEPT INC (7)
BIOCRYST PHARMACEUTICALS INC (18)
Biogen Inc. (17)
Biohaven Pharmaceutical Holding Co Ltd. (5)
BioLife4D Corp (1)
BIOMARIN PHARMACEUTICAL INC (13)
Biomea Fusion, Inc. (6)
BioRestorative Therapies, Inc. (11)
BIOSPECIFICS TECHNOLOGIES CORP (1)
Biostage, Inc. (8)
BIOTIME INC (6)
BioXcel Therapeutics, Inc. (8)
Black Diamond Therapeutics, Inc. (3)
Blue Water Vaccines Inc. (12)
bluebird bio, Inc. (4)
Blueprint Medicines Corp (13)
Bolt Biotherapeutics, Inc. (6)
Bone Biologics Corp (3)
BRAINSTORM CELL THERAPEUTICS INC. (7)
BridgeBio Pharma, Inc. (8)
C4 Therapeutics, Inc. (3)
Cabaletta Bio, Inc. (1)
CALADRIUS BIOSCIENCES, INC. (2)
Calithera Biosciences, Inc. (6)
Calyxt, Inc. (19)
CANCER GENETICS, INC (7)
Candel Therapeutics, Inc. (2)
CAPRICOR THERAPEUTICS, INC. (5)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (2)
Capstone Therapeutics Corp. (8)
CareDx, Inc. (12)
Caribou Biosciences, Inc. (11)
CASI Pharmaceuticals, Inc. (13)
CASTLE BIOSCIENCES INC (7)
Castle Creek Biosciences, Inc. (2)
CATABASIS PHARMACEUTICALS INC (10)
CATALYST BIOSCIENCES, INC. (30)
CATALYST PHARMACEUTICALS, INC. (2)
Celcuity Inc. (10)
Cell Source, Inc. (3)
Celldex Therapeutics, Inc. (14)
Cellectar Biosciences, Inc. (18)
Cellular Biomedicine Group, Inc. (2)
Celsion CORP (13)
Centessa Pharmaceuticals Ltd (1)
Century Therapeutics, Inc. (3)
Chanticleer Holdings, Inc. (2)
Chardan Healthcare Acquisition 2 Corp. (3)
Chardan Healthcare Acquisition Corp. (3)
Checkpoint Therapeutics, Inc. (4)
Chelsea Worldwide Inc. (1)
ChemoCentryx, Inc. (8)
CHIMERIX INC (9)
Cibus Global, Ltd. (1)
Cidara Therapeutics, Inc. (8)
CLEVELAND BIOLABS INC (5)
Clovis Oncology, Inc. (4)
CM Life Sciences III Inc. (3)
Codiak BioSciences, Inc. (3)
CohBar, Inc. (5)
Coherus BioSciences, Inc. (11)
Comera Life Sciences Holdings, Inc. (2)
COMPASS Pathways plc (2)
Conatus Pharmaceuticals Inc. (10)
CONCERT PHARMACEUTICALS, INC. (6)
Consonance-HFW Acquisition Corp. (4)
Constellation Alpha Capital Corp. (7)
CONSTELLATION PHARMACEUTICALS INC (5)
CONTRAFECT Corp (6)
Corbus Pharmaceuticals Holdings, Inc. (2)
Cortexyme, Inc. (3)
Corvus Pharmaceuticals, Inc. (1)
Crinetics Pharmaceuticals, Inc. (9)
CRISPR Therapeutics AG (16)
CTD HOLDINGS INC (1)
CTI BIOPHARMA CORP (32)
Cue Biopharma, Inc. (9)
Cullinan Oncology, LLC (2)
Curative Biotechnology Inc (8)
CURIS INC (9)
Cyclacel Pharmaceuticals, Inc. (10)
Cyclerion Therapeutics, Inc. (2)
CytoDyn Inc. (11)
Cytokinetics, Incorporated (12)
CytomX Therapeutics, Inc. (9)
CYTORI THERAPEUTICS, INC. (12)
CYTRX CORP (13)
Day One Biopharmaceuticals Holding Co LLC (2)
Decibel Therapeutics, Inc. (10)
DECIPHER BIOSCIENCES, INC. (2)
Deciphera Pharmaceuticals, Inc. (11)
DelMar Pharmaceuticals, Inc. (9)
Denali Therapeutics Inc. (2)
Dermavant Sciences Ltd (3)
Dermira, Inc. (4)
Design Therapeutics, Inc. (3)
DiaMedica Therapeutics Inc. (10)
Dicerna Pharmaceuticals Inc (9)
Diffusion Pharmaceuticals Inc. (5)
DYADIC INTERNATIONAL INC (4)
Dynamics Special Purpose Corp. (2)
DYNAVAX TECHNOLOGIES CORP (10)
Dyne Therapeutics, Inc. (12)
Eagle Pharmaceuticals, Inc. (9)
Edge Therapeutics, Inc. (9)
Editas Medicine, Inc. (6)
Eidos Therapeutics, Inc. (8)
Eiger BioPharmaceuticals, Inc. (11)
Elevation Oncology, Inc. (2)
Eliem Therapeutics, Inc. (5)
Emerald Bioscience, Inc. (11)
Emergent BioSolutions Inc. (5)
Enanta Pharmaceuticals, Inc. (26)
Enochian Biosciences Inc (4)
Entasis Therapeutics Holdings Inc. (13)
Entrada Therapeutics, Inc. (3)
Environmental Impact Acquisition Corp (1)
ENZON PHARMACEUTICALS, INC. (4)
Epizyme, Inc. (13)
Equillium, Inc. (3)
Erasca, Inc. (2)
Esperion Therapeutics, Inc. (6)
Evelo Biosciences, Inc. (4)
EVOLUTIONARY GENOMICS, INC. (1)
EXACT SCIENCES CORP (19)
Exelixis (31)
EXICURE, INC. (2)
FATE THERAPEUTICS INC (10)
FENNEC PHARMACEUTICALS INC. (1)
Fibrocell Science, Inc. (9)
FIBROGEN INC (5)
Finch Therapeutics Group, Inc. (5)
FIVE PRIME THERAPEUTICS INC (13)
Flex Pharma, Inc. (4)
Flexion Therapeutics Inc (3)
FLUOROPHARMA MEDICAL, INC. (1)
Foghorn Therapeutics Inc. (9)
Forma Therapeutics Holdings, Inc., (3)
Fortress Biotech, Inc. (7)
Forty Seven, Inc. (6)
Frequency Therapeutics, Inc. (7)
FS Development Corp. (2)
FS Development Corp. II (3)
Fusion Pharmaceuticals Inc. (3)
G1 Therapeutics, Inc. (8)
Gain Therapeutics, Inc. (2)
GALECTIN THERAPEUTICS INC (4)
Galecto Inc. (5)
Galera Therapeutics, Inc. (5)
Gamida Cell Ltd. (6)
Gemphire Therapeutics Inc. (11)
Gene Biotherapeutics, Inc. (1)
GENELUX CORP (7)
Generation Bio Co. (7)
GENEREX BIOTECHNOLOGY CORP (1)
GENOCEA BIOSCIENCES, INC. (14)
Genprex, Inc. (4)
GeoVax Labs, Inc. (6)
GERON CORP (25)
Gilead Sciences (78)
Global Blood Therapeutics, Inc. (6)
GLYCOMIMETICS INC (10)
Gossamer Bio, Inc. (7)
Grail, Inc. (6)
Graphite Bio, Inc. (4)
Greenwich LifeSciences, Inc. (1)
Gritstone Oncology, Inc. (8)
GT Biopharma, Inc. (1)
GTX INC (19)
GX Acquisition Corp. (4)
HALOZYME THERAPEUTICS INC (2)
Harpoon Therapeutics, Inc. (4)
HCW Biologics Inc. (4)
Health Sciences Acquisitions Corp (3)
HEAT BIOLOGICS, INC. (14)
HEMISPHERX BIOPHARMA INC (3)
HERON THERAPEUTICS, INC. (4)
HilleVax, Inc. (2)
Hillstream BioPharma Inc. (2)
HISTOGENICS CORP (10)
Homology Medicines, Inc. (7)
HOOKIPA Pharma Inc. (9)
HUMANIGEN, INC (9)
iBio, Inc. (11)
Icosavax, Inc. (3)
IDEAYA Biosciences, Inc. (8)
IDERA PHARMACEUTICALS, INC. (25)
IGM Biosciences, Inc. (6)
Imago BioSciences, Inc. (7)
Immix Biopharma, Inc. (3)
IMMUCELL CORP (18)
IMMUNE PHARMACEUTICALS INC (2)
Immuneering Corp (3)
ImmunoCellular Therapeutics, Ltd. (8)
IMMUNOGEN INC (34)
Immunome Inc. (6)
IMMUNOMEDICS INC (13)
IMPEL NEUROPHARMA INC (4)
IN8BIO, INC. (8)
Incyte (29)
INFINITY PHARMACEUTICALS, INC. (13)
Inhibikase Therapeutics, Inc. (5)
Inhibrx, Inc. (10)
Inmune Bio, Inc. (7)
Innovation Pharmaceuticals Inc. (4)
INOVIO PHARMACEUTICALS, INC. (13)
Inozyme Pharma, Inc. (6)
INSMED Inc (47)
Inspyr Therapeutics, Inc. (1)
Instil Bio, Inc. (6)
Intec Parent Inc. (3)
Intec Pharma Ltd. (1)
Intellia Therapeutics, Inc. (5)
INTERCEPT PHARMACEUTICALS, INC. (17)
INTREXON CORP (22)
Intrinsic Medicine, Inc. (2)
Invitae Corp (29)
IONIS PHARMACEUTICALS INC (6)
IOVANCE BIOTHERAPEUTICS, INC. (18)
IRONWOOD PHARMACEUTICALS INC (19)
Isoray, Inc. (5)
iTeos Therapeutics, Inc. (2)
Janux Therapeutics, Inc. (4)
Jounce Therapeutics, Inc. (4)
Kadmon Holdings, Inc. (7)
KalVista Pharmaceuticals, Inc. (3)
Karuna Therapeutics, Inc. (10)
Karyopharm Therapeutics Inc. (21)
KBL MERGER CORP. IV (7)
Keros Therapeutics, Inc. (6)
Kezar Life Sciences, Inc. (7)
Kindred Biosciences, Inc. (8)
Kiniksa Pharmaceuticals, Ltd. (13)
Kinnate Biopharma Inc. (3)
Kiromic Biopharma, Inc. (1)
Kodiak Sciences Inc. (7)
Kronos Bio, Inc. (1)
Krystal Biotech, Inc. (9)
Kura Oncology, Inc. (6)
Kymera Therapeutics, Inc. (3)
LA JOLLA PHARMACEUTICAL CO (4)
Lantern Pharma Inc. (2)
LEAP THERAPEUTICS, INC. (3)
Leisure Acquisition Corp. (4)
LEXICON PHARMACEUTICALS, INC. (22)
LianBio (5)
LifeSci Acquisition Corp. (4)
Ligand Pharmaceuticals Incorporated (3)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (2)
Locust Walk Acquisition Corp. (5)
LogicBio Therapeutics, Inc. (7)
LONGEVERON LLC (2)
Lyell Immunopharma, Inc. (5)
MACROGENICS INC (11)
MADRIGAL PHARMACEUTICALS, INC. (1)
Magenta Therapeutics, Inc. (5)
MAIA Biotechnology, Inc. (10)
MANNKIND CORP (5)
MARIZYME INC (9)
Marker Therapeutics, Inc. (4)
MATEON THERAPEUTICS INC (6)
Matinas BioPharma Holdings, Inc. (1)
MAXCYTE, INC. (10)
MEDICINOVA INC (6)
Medovex Corp. (1)
MeiraGTx Holdings plc (8)
MERRIMACK PHARMACEUTICALS INC (2)
Mersana Therapeutics, Inc. (8)
Metacrine, Inc. (4)
Millendo Therapeutics, Inc. (24)
MiMedx Group, Inc. (40)
Minerva Neurosciences, Inc. (4)
MiNK Therapeutics, Inc. (10)
MIRAGEN THERAPEUTICS, INC. (25)
Mirati Therapeutics, Inc. (4)
Mirum Pharmaceuticals, Inc. (9)
Moderna, Inc. (2)
Molecular Templates, Inc. (8)
Momenta Pharmaceuticals, Inc. (28)
Monopar Therapeutics (6)
Monte Rosa Therapeutics, Inc. (2)
Morphic Holding, Inc. (4)
MUSTANG BIO, INC. (2)
Myovant Sciences Ltd. (11)
Myriad Genetics, Inc. (18)
NantKwest, Inc. (6)
Natera, Inc. (4)
NAVIDEA BIOPHARMACEUTICALS, INC. (7)
NEUROCRINE BIOSCIENCES INC (11)
NEUROTROPE BIOSCIENCE, INC. (7)
Neurotrope, Inc. (5)
NEWLINK GENETICS CORP (14)
NexImmune, Inc. (6)
NextCure, Inc. (7)
Nkarta, Inc. (3)
NOVAVAX INC (13)
Novus Therapeutics, Inc. (14)
NTN BUZZTIME INC (28)
Nuo Therapeutics, Inc. (5)
Nurix Therapeutics, Inc. (2)
Nuvalent, Inc. (4)
Nuvectis Pharma, Inc. (1)
Ohr Pharmaceutical Inc (7)
Olema Pharmaceuticals, Inc. (4)
Olivia Ventures, Inc. (2)
Omega Therapeutics, Inc. (3)
OncoCyte Corp (2)
Oncorus, Inc. (6)
ONCOSEC MEDICAL Inc (2)
OPGEN INC (7)
Ophthotech Corp. (13)
Opko Health, Inc. (2)
ORAGENICS INC (11)
Orchard Therapeutics plc (2)
Organicell Regenerative Medicine, Inc. (2)
Organogenesis Holdings Inc. (3)
ORGANOVO HOLDINGS, INC. (18)
Orgenesis Inc. (1)
Oric Pharmaceuticals, Inc. (4)
Outlook Therapeutics, Inc. (6)
Ovid Therapeutics Inc. (10)
Oyster Point Pharma, Inc. (5)
PALATIN TECHNOLOGIES INC (11)
Pasithea Therapeutics Corp. (2)
Passage BIO, Inc. (2)
PDL BIOPHARMA, INC. (24)
PepGen Inc. (2)
Pfenex Inc. (7)
PharmaCyte Biotech, Inc. (1)
PhaseBio Pharmaceuticals Inc (5)
Phio Pharmaceuticals Corp. (9)
PIERIS PHARMACEUTICALS, INC. (14)
PMV Pharmaceuticals, Inc. (5)
POLARITYTE, INC. (22)
PORTOLA PHARMACEUTICALS INC (11)
Poseida Therapeutics, Inc. (5)
Praxis Precision Medicines, Inc. (10)
PRECISION BIOSCIENCES INC (5)
Prelude Therapeutics Inc (2)
Prevail Therapeutics Inc. (2)
Principia Biopharma Inc. (4)
Progenics Pharmaceuticals, Inc. (8)
PROGENITY, INC. (8)
Prometheus Biosciences, Inc. (3)
ProMIS Neurosciences Inc. (1)
Propanc Biopharma, Inc. (1)
Protagenic Therapeutics, Inc. (3)
Protagonist Therapeutics, Inc (2)
Protalix BioTherapeutics, Inc. (5)
PROTEON THERAPEUTICS INC (8)
PROTEOSTASIS THERAPEUTICS, INC. (6)
Prothena Corp plc (25)
ProtoKinetix, Inc. (5)
PTC THERAPEUTICS, INC. (18)
PUMA BIOTECHNOLOGY, INC. (11)
Pyxis Oncology, Inc. (2)
Q BioMed Inc. (1)
Radius Health, Inc. (16)
Rallybio Corp (7)
RAPT Therapeutics, Inc. (3)
Rasna Therapeutics Inc. (1)
RECURSION PHARMACEUTICALS, INC. (3)
Regeneron Pharmaceuticals (38)
REGENERX BIOPHARMACEUTICALS INC (4)
REGENXBIO Inc. (6)
Regulus Therapeutics Inc. (6)
Relay Therapeutics, Inc. (2)
Reneo Pharmaceuticals, Inc. (16)
RenovaCare, Inc. (4)
RenovoRx, Inc. (6)
Repare Therapeutics Inc. (3)
Replimune Group, Inc. (3)
Retrophin, Inc. (8)
Revolution Medicines, Inc. (6)
REXAHN PHARMACEUTICALS, INC. (6)
Rezolute, Inc. (1)
RHYTHM PHARMACEUTICALS, INC. (4)
RIGEL PHARMACEUTICALS INC (35)
RITTER PHARMACEUTICALS INC (8)
ROCKET PHARMACEUTICALS, INC. (9)
Rubius Therapeutics, Inc. (3)
Sage Therapeutics, Inc. (7)
Sana Biotechnology, Inc. (12)
SANGAMO THERAPEUTICS, INC (9)
SANGUI BIOTECH INTERNATIONAL INC (1)
Sarepta Therapeutics, Inc. (34)
Savara Inc (45)
Scholar Rock Holding Corp (1)
SEATTLE GENETICS INC (74)
SELECTA BIOSCIENCES INC (5)
SELLAS Life Sciences Group, Inc. (14)
Sensei Biotherapeutics, Inc. (2)
SERA PROGNOSTICS, INC. (4)
Seres Therapeutics, Inc. (4)
Sesen Bio, Inc. (14)
Shattuck Labs, Inc. (3)
Shuttle Pharmaceuticals Holdings, Inc. (1)
Sierra Oncology, Inc. (3)
Sigilon Therapeutics, Inc. (9)
Silverback Therapeutics, Inc. (3)
Social Capital Suvretta Holdings Corp. III (2)
SOLENO THERAPEUTICS INC (8)
Solid Biosciences Inc. (17)
SOLIGENIX, INC. (7)
Sorrento Therapeutics, Inc. (5)
Spectrum Pharmaceuticals, Inc. (18)
Spero Therapeutics, Inc. (16)
SPHERIX INC (3)
Spinning Eagle Acquisition Corp. (3)
Spring Bank Pharmaceuticals, Inc. (14)
SpringWorks Therapeutics, Inc. (3)
SPRUCE BIOSCIENCES, INC. (6)
SQZ Biotechnologies Co (4)
Stellar Biotechnologies, Inc. (4)
Stoke Therapeutics, Inc. (3)
Sun BioPharma, Inc. (5)
SUNESIS PHARMACEUTICALS INC (27)
Surface Oncology, Inc. (8)
SUTRO BIOPHARMA, INC. (3)
Syndax Pharmaceuticals Inc (8)
SYNLOGIC, INC. (18)
Synthetic Biologics, Inc. (1)
Syros Pharmaceuticals, Inc. (8)
T2 Biosystems, Inc. (6)
Talaris Therapeutics, Inc. (7)
Taysha Gene Therapies, Inc. (3)
TCR2 THERAPEUTICS INC. (3)
TENAX THERAPEUTICS, INC. (11)
Tenaya Therapeutics, Inc. (5)
TG THERAPEUTICS, INC. (3)
Therapeutics Acquisition Corp. (9)
Tocagen Inc (10)
Tracon Pharmaceuticals, Inc. (7)
Transcode Therapeutics, Inc. (2)
Translate Bio, Inc. (10)
TREVENA INC (9)
TScan Therapeutics, Inc. (5)
Turning Point Therapeutics, Inc. (3)
Twist Bioscience Corp (2)
TYME TECHNOLOGIES, INC. (3)
Tyra Biosciences, Inc. (2)
Ultragenyx Pharmaceutical Inc. (18)
Unicycive Therapeutics, Inc. (2)
uniQure N.V. (13)
United Therapeutics Corp (22)
Unity Biotechnology, Inc. (7)
Unum Therapeutics Inc. (6)
UroGen Pharma Ltd. (14)
VACCINEX, INC. (3)
Vaccitech plc (1)
Vanda Pharmaceuticals Inc. (16)
Vaxart, Inc. (11)
Vaxcyte, Inc. (5)
Vaxxinity, Inc. (4)
VBI Vaccines Inc (1)
Vera Therapeutics, Inc. (5)
VERACYTE, INC. (10)
Verastem, Inc. (24)
Vericel Corp (31)
Vertex Pharmaceuticals Inc (1)
Verve Therapeutics, Inc. (10)
VICAL INC (14)
Viela Bio, Inc. (2)
Vigil Neuroscience, Inc. (3)
Viking Therapeutics, Inc. (7)
Vir Biotechnology, Inc. (7)
Virios Therapeutics, LLC (2)
VistaGen Therapeutics, Inc. (5)
VITAL THERAPIES INC (8)
VITRO DIAGNOSTICS INC (4)
Vor Biopharma Inc. (3)
Voyager Therapeutics, Inc. (1)
vTv Therapeutics Inc. (3)
Werewolf Therapeutics, Inc. (8)
WINDTREE THERAPEUTICS INC (13)
XBiotech Inc. (4)
Xencor Inc (4)
Xenetic Biosciences, Inc. (1)
Xenon Pharmaceuticals Inc. (7)
Xilio Therapeutics, Inc. (10)
XOMA Corp (11)
Y-mAbs Therapeutics, Inc. (9)
YIELD10 BIOSCIENCE, INC. (11)
ZAFGEN, INC. (5)
Zai Lab Ltd (2)
Zentalis Pharmaceuticals, LLC (5)
ZIOPHARM ONCOLOGY INC (10)
Zymeworks Inc. (1)

Recent Contracts

Jade Biosciences, Inc. Amended and Restated 2024 Equity Incentive Plan and the Form of Stock Option Agreement thereunder (Aerovate Therapeutics, Inc., Filed With SEC on December 3, 2024)
Form of Relative Total Stockholder Return Unit Certificate under 2024 Inducement Stock Incentive Plan (Enanta Pharmaceuticals, Inc., Filed With SEC on November 27, 2024)
Form of Performance Share Unit Certificate under 2024 Inducement Stock Incentive Plan (Enanta Pharmaceuticals, Inc., Filed With SEC on November 27, 2024)
Form of Notice of Grant of Restricted Stock Unit Award under 2024 Inducement Stock Incentive Plan (Enanta Pharmaceuticals, Inc., Filed With SEC on November 27, 2024)
Form of Notice of Grant of Non-Statutory Stock Option under 2024 Inducement Stock Incentive Plan (Enanta Pharmaceuticals, Inc., Filed With SEC on November 27, 2024)
Organovo Holdings, Inc. – Amended and Restated 2022 Equity Incentive Plan (ORGANOVO HOLDINGS, INC., Filed With SEC on November 22, 2024)
Biora Therapeutics, Inc. Sixth Amended & Restated 2018 Equity Incentive Plan (PROGENITY, INC., Filed With SEC on November 15, 2024)
Form of Stock Option Agreement under 2024 Equity Incentive Plan (DelMar Pharmaceuticals, Inc., Filed With SEC on November 15, 2024)
Form of Restricted Stock Unit Agreement under the Company's 2019 Omnibus Long-Term Incentive Plan (Chardan Healthcare Acquisition Corp., Filed With SEC on November 14, 2024)
Amendment to Retention Bonus Letter Agreement, dated November 13, 2024, by and between T2 Biosystems, Inc. and Michael Gibbs (T2 Biosystems, Inc., Filed With SEC on November 14, 2024)
Amendment to Retention Bonus Letter Agreement, dated November 13, 2024, by and between T2 Biosystems, Inc. and John Sprague (T2 Biosystems, Inc., Filed With SEC on November 14, 2024)
bluebird bio, Inc. 2023 Incentive Award Plan, as amended and restated, and forms of award agreements thereunder (bluebird bio, Inc., Filed With SEC on November 14, 2024)
GRAIL, Inc. 2024 Inducement Incentive Award Plan (Grail, Inc., Filed With SEC on November 13, 2024)
Form of Deferred Restricted Stock Unit Agreement (2024 Incentive Award Plan) (Grail, Inc., Filed With SEC on November 13, 2024)
Amendment to Retention Bonus Agreement by and between Synlogic, Inc. and Mary Beth Dooley, dated as of March 7, 2024 (SYNLOGIC, INC., Filed With SEC on November 12, 2024)
Amendment to Retention Bonus Agreement by and between Synlogic, Inc. and Antoine Awad, dated as of March 7, 2024 (SYNLOGIC, INC., Filed With SEC on November 12, 2024)
BioRestorative Therapies, Inc. 2021 Stock Incentive Plan, as amended (BioRestorative Therapies, Inc., Filed With SEC on November 12, 2024)
Form of Restricted Stock Unit Award Agreement under the 2024 Omnibus Incentive Plan (Savara Inc, Filed With SEC on November 12, 2024)
Form of Nonqualified Stock Option Award Agreement under the 2024 Omnibus Incentive Plan (Savara Inc, Filed With SEC on November 12, 2024)
Form of Incentive Stock Option Award Agreement under the 2024 Omnibus Incentive Plan (Savara Inc, Filed With SEC on November 12, 2024)
Skye Bioscience, Inc. Amended and Restated Omnibus Incentive Plan (Emerald Bioscience, Inc., Filed With SEC on November 7, 2024)
Forms of Standard Performance Stock Unit Grant Notice and Performance Stock Unit Agreement under the Acadia Pharmaceuticals Inc. 2024 Inducement Plan (ACADIA PHARMACEUTICALS INC, Filed With SEC on November 7, 2024)
Form of Performance-Based Restricted Stock Unit Grant Notice and Award Agreement, under the Company's 2021 Equity Incentive Plan (Century Therapeutics, Inc., Filed With SEC on November 5, 2024)
Amendment No. 2 to the Theriva Biologics, Inc. 2020 Stock Incentive Plan (Synthetic Biologics, Inc., Filed With SEC on November 1, 2024)
Amendment No. 2 to the Tenax Therapeutics, Inc. 2022 Stock Incentive Plan (TENAX THERAPEUTICS, INC., Filed With SEC on October 30, 2024)
Form of U.S. Restricted Stock Unit Award Agreement for Executive Officers under the Incyte Corporation 2024 Inducement Stock Incentive Plan (Incyte, Filed With SEC on October 29, 2024)
Form of U.S. Nonstatutory Stock Option Agreement for Executive Officers under the Incyte Corporation 2024 Inducement Stock Incentive Plan (Incyte, Filed With SEC on October 29, 2024)
Form of U.S. Restricted Stock Unit Award Agreement under the Incyte Corporation Amended and Restated 2010 Stock Incentive Plan (Incyte, Filed With SEC on October 29, 2024)
Form of U.S. Stock Option Agreement for Executive Officers under the Incyte Corporation Amended and Restated 2010 Stock Incentive Plan (Incyte, Filed With SEC on October 29, 2024)
TuHURA Biosciences, Inc. 2024 Equity Incentive Plan (DelMar Pharmaceuticals, Inc., Filed With SEC on October 21, 2024)
Amended and Restated 2018 Equity Incentive Plan (OncoCyte Corp, Filed With SEC on October 15, 2024)
OnKure Therapeutics, Inc. Executive Incentive Compensation Plan (Reneo Pharmaceuticals, Inc., Filed With SEC on October 8, 2024)
OnKure, Inc. 2023 RSU Equity Incentive Plan, and forms of agreement thereunder (Reneo Pharmaceuticals, Inc., Filed With SEC on October 8, 2024)
OnKure, Inc. 2021 Stock Incentive Plan, as amended, and forms of agreement thereunder (Reneo Pharmaceuticals, Inc., Filed With SEC on October 8, 2024)
OnKure, Inc. 2011 Stock Incentive Plan, as amended, and forms of agreement thereunder (Reneo Pharmaceuticals, Inc., Filed With SEC on October 8, 2024)
OnKure Therapeutics, Inc. 2024 Equity Incentive Plan, and forms of agreement thereunder (Reneo Pharmaceuticals, Inc., Filed With SEC on October 8, 2024)
Tenaya Therapeutics, Inc. 2024 Inducement Equity Incentive Plan and related forms of stock option and restricted stock unit agreements (Tenaya Therapeutics, Inc., Filed With SEC on September 16, 2024)
Amendment No. 4 to Brainstorm Cell Therapeutics Inc. 2014 Stock Incentive Plan (BRAINSTORM CELL THERAPEUTICS INC., Filed With SEC on September 16, 2024)
Form of Performance-Based Restricted Stock Unit Agreement under the bluebird bio, Inc. 2023 Incentive Award Plan (bluebird bio, Inc., Filed With SEC on September 13, 2024)
Second Amendment to Amended and Restated Oruka Therapeutics, Inc. 2024 Equity Incentive Plan, effective as of May 7, 2024 (ARCA biopharma, Inc., Filed With SEC on September 5, 2024)